专题:Pharmaceutical industry and healthcare

This cluster of papers explores the impact of pharmaceutical industry sponsorship on research outcome and quality, including conflicts of interest, financial ties between physicians and industry, direct-to-consumer advertising, publication bias, and ethical considerations in medical practice. The papers investigate the influence of funding sources on clinical trials, prescribing behavior, and the integrity of medical science.
最新文献
CLINICAL DECISION-MAKING CRITERIA FOR SWITCHING OR COMBINING ANTIHYPERTENSIVE MEDICATIONS: A PHYSICIAN-BASED SURVEY

article Full Text OpenAlex

Global trends in antibiotic expenditure: analysis of pharmaceutical sales data, 2013 to 2023

article Full Text OpenAlex

Transparency in Ophthalmology Markets

article Full Text OpenAlex

Beyond Patient Satisfaction: Positioning Responsiveness as a Strategic Lever in Hospital Marketing and Business Growth

article Full Text OpenAlex

Anabolic-androgenic steroid testing as a tool for consumer engagement and harm reduction: a sequential explanatory mixed-method study

article Full Text OpenAlex

US government announces “largest healthcare fraud takedown in history”

article Full Text OpenAlex

Omnichannel Pharmaceutical Marketing: Driving HCP and Patient Engagement to Boost Brand Performance

article Full Text OpenAlex

Ethical Marketing and Brand Management of Prescription Drugs

article Full Text OpenAlex

United States trends in non‐prescribed use of Adderall and Ritalin: Population Assessment of Tobacco and Health (PATH) Study estimates from 2013 to 2022

article Full Text OpenAlex

Reporting quality of randomized controlled trial abstracts presented at the European Orthodontic Society Congress between 2015–2024: has there been an improvement over time?

article Full Text OpenAlex

近5年高被引文献
Responsible Conduct of Research

book Full Text OpenAlex 202 FWCI48.135

Good Publication Practice (GPP) Guidelines for Company-Sponsored Biomedical Research: 2022 Update

article Full Text OpenAlex 175 FWCI35.989

Exploring the consequences of greater price transparency on the dynamics of pharmaceutical markets

paratext Full Text OpenAlex 130 FWCI0

Medication Without Harm

article Full Text OpenAlex 123 FWCI16.97

Market strategies used by processed food manufacturers to increase and consolidate their power: a systematic review and document analysis

review Full Text OpenAlex 108 FWCI5.256

Impact of Patient Engagement on Healthcare Quality: A Scoping Review

review Full Text OpenAlex 106 FWCI7.973

The gendered nature of authorship

article Full Text OpenAlex 104 FWCI5.144

The Science for Profit Model—How and why corporations influence science and the use of science in policy and practice

article Full Text OpenAlex 86 FWCI10.808

PRILE 2021 guidelines for reporting laboratory studies in Endodontology: explanation and elaboration

review Full Text OpenAlex 83 FWCI3.539

Trends in Prescription Drug Launch Prices, 2008-2021

article Full Text OpenAlex 75 FWCI13.225